Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients

MLA

Erika Cecchin, et al. Integration of DNA Sequencing with Population Pharmacokinetics to Improve the Prediction of Irinotecan Exposure in Cancer Patients. Mar. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....62ea219d07ad99d5cc228e98f7bdd0c6&authtype=sso&custid=ns315887.

APA

Erika Cecchin, Giuseppe Toffoli, Federico Innocenti, Alan Forrest, Deborah A. Nickerson, Amy S. Etheridge, Nancy J. Cox, Spinel Karas, Robert R. Bies, Karen L. Mohlke, & Ron H.J. Mathijssen. (2022). Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients.

Chicago

Erika Cecchin, Giuseppe Toffoli, Federico Innocenti, Alan Forrest, Deborah A. Nickerson, Amy S. Etheridge, Nancy J. Cox, et al. 2022. “Integration of DNA Sequencing with Population Pharmacokinetics to Improve the Prediction of Irinotecan Exposure in Cancer Patients,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....62ea219d07ad99d5cc228e98f7bdd0c6&authtype=sso&custid=ns315887.